Which disease is characterized by malignant plasma cells in the bone marrow?

The Nightingale Pathophysiology Test is your destination for mastering complex medical concepts. Utilize multiple choice questions and flashcards, all with detailed explanations. Enhance your understanding and boost your confidence. Prepare effectively for your exam!

Multiple Choice

Which disease is characterized by malignant plasma cells in the bone marrow?

Explanation:
Malignant plasma cells in the bone marrow point to a plasma cell neoplasm, most characteristically multiple myeloma. In this disease, clonal plasma cells accumulate in the marrow, crowding out normal blood-forming cells and often secreting a monoclonal immunoglobulin (the M protein) detectable in blood or urine. This marrow invasion leads to bone destruction with lytic lesions, bone pain, anemia from reduced red cell production, hypercalcemia, and kidney dysfunction due to light chains. The other conditions involve different cell types or sites—leukemia involves malignant leukocytes in blood/marrow but not specifically plasma cells; lymphoma centers on lymphoid tissues; hypersplenism is about sequestration in an enlarged spleen. Thus, the description best fits multiple myeloma.

Malignant plasma cells in the bone marrow point to a plasma cell neoplasm, most characteristically multiple myeloma. In this disease, clonal plasma cells accumulate in the marrow, crowding out normal blood-forming cells and often secreting a monoclonal immunoglobulin (the M protein) detectable in blood or urine. This marrow invasion leads to bone destruction with lytic lesions, bone pain, anemia from reduced red cell production, hypercalcemia, and kidney dysfunction due to light chains. The other conditions involve different cell types or sites—leukemia involves malignant leukocytes in blood/marrow but not specifically plasma cells; lymphoma centers on lymphoid tissues; hypersplenism is about sequestration in an enlarged spleen. Thus, the description best fits multiple myeloma.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy